- $356.65m
- $266.95m
- $295.94m
- 55
- 57
- 54
- 55
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 16.35 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.97 | ||
| Price to Tang. Book | 3.47 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.21 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -20.71% | ||
| Return on Equity | -29.84% | ||
| Operating Margin | -42.88% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 154.94 | 188.84 | 241.93 | 276.24 | 295.94 | 308.69 | 344.82 | 21.33% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +57.5 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Health Catalyst, Inc. is a provider of data and analytics technology and services to healthcare organizations. The Company’s solution comprises its cloud-based data and analytics platform, software applications, and professional services expertise. The Company operates through two segments: Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and is focused primarily on contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its customers to fully configure and utilize the benefits of its technology offerings. Its clients include academic medical centers, integrated delivery networks, community hospitals, physician practices, health insurers, and others.
Directors
- John Kane NEC (68)
- J. Patrick Nelli PRE (34)
- Daniel Burton CEO (46)
- Bryan Hunt CFO (34)
- Paul Horstmeier COO (60)
- Linda Llewelyn CHO (54)
- Bryan Hinton CTO (43)
- Jason Alger CAO (37)
- Daniel Orenstein GCN (51)
- Fraser Bullock IND (65)
- Duncan Gallagher IND (61)
- Julie Larson-Green IND (59)
- Anita Pramoda IND (46)
- S. Dawn Smith IND (57)
- Mark Templeton IND (68)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- September 20th, 2011
- Public Since
- July 25th, 2019
- No. of Shareholders
- 128
- No. of Employees
- 728
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
NASDAQ Global Select Market- Shares in Issue
- 58,563,005
- Address
- 10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN, 84095
- Web
- https://www.healthcatalyst.com/
- Phone
- +1 8017086800
- Contact
- Adam Brown
- Auditors
- Ernst & Young LLP
Upcoming Events for HCAT
Health Catalyst Inc Annual Shareholders Meeting
Q2 2024 Health Catalyst Inc Earnings Release
Similar to HCAT
2U
NASDAQ Global Select Market
ACV Auctions
NASDAQ Global Select Market
Adeia
NASDAQ Global Select Market
Adobe
NASDAQ Global Select Market
Agilysys
NASDAQ Global Select Market
FAQ
What is the Health Catalyst share price?
As of Today at 19:10 UTC, shares in Health Catalyst are trading at $6.09. This share price information is delayed by 15 minutes.
How has the Health Catalyst share price performed this year?
Shares in Health Catalyst last closed at $6.09 and the price had moved by -52.46% over the past 365 days. In terms of relative price strength the Health Catalyst share price has underperformed the S&P500 Index by -61.61% over the past year.
What are the analyst and broker recommendations for Health Catalyst?
The overall consensus recommendation for Health Catalyst is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Health Catalyst dividend yield?
Health Catalyst does not currently pay a dividend.
Does Health Catalyst pay a dividend?
Health Catalyst does not currently pay a dividend.
When does Health Catalyst next pay dividends?
Health Catalyst does not currently pay a dividend.
How do I buy Health Catalyst shares?
To buy shares in Health Catalyst you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Health Catalyst?
As of the previous close price of $6.09, shares in Health Catalyst had a market capitalisation of $356.65m.
Where are Health Catalyst shares listed?
Here are the trading details for Health Catalyst:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: HCAT
What kind of share is Health Catalyst?
Based on an overall assessment of its quality, value and momentum Health Catalyst is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Health Catalyst share price forecast for 2024?
The analyst consensus target price for shares in Health Catalyst is $11.93. That is 95.89% above the last closing price of $6.09.
Analysts covering Health Catalyst currently have a consensus Earnings Per Share (EPS) forecast of $0.32 for the next financial year.
What is the trend in the Health Catalyst share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Health Catalyst. Over the past six months, its share price has underperformed the S&P500 Index by -37.74%.
As of the last closing price of $6.09, shares in Health Catalyst were trading -36.79% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Health Catalyst PE Ratio?
The Health Catalyst PE ratio based on its reported earnings over the past 12 months is 16.35. The shares last closed at $6.09.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Health Catalyst?
Health Catalyst's management team is headed by:
- John Kane - NEC
- J. Patrick Nelli - PRE
- Daniel Burton - CEO
- Bryan Hunt - CFO
- Paul Horstmeier - COO
- Linda Llewelyn - CHO
- Bryan Hinton - CTO
- Jason Alger - CAO
- Daniel Orenstein - GCN
- Fraser Bullock - IND
- Duncan Gallagher - IND
- Julie Larson-Green - IND
- Anita Pramoda - IND
- S. Dawn Smith - IND
- Mark Templeton - IND